[Medical treatment options in BRCA-associated cancers].

Abstract excerpt

Germinal or somatic mutations of the BRCA genes may serve as therapeutic targets. Deficient functioning of the BRCA genes render the cancer vulnerable to such therapeutic interventions as chemotherapy with DNA-targeted agents and PARP inhibitors targeting DNA repair capacity. Although BRCA mutations may be detected in a large variety of cancers, the mentioned specific therapies are efficient in the so called...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genes, BRCA1
• Share to Genes, BRCA2
• Share to Mutation